Skip to main content

Table 2 Linear regression analysis assessing the effects of potential risk factors on plaque volume progression

From: Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study

Variablesa

Univariate

Multivariateb

95%CI

P-value

95%CI

P-value

Annual change in TPV

 CV-HbA1C

0.242

0.062, 0.438

0.004

0.241

0.019, 0.462

0.034

 HbA1C

0.250

0.154, 0.346

 < 0.001

0.275

0.073, 0.477

0.009

 CV-FPG

0.233

0.076, 0.420

0.003

0.265

0.060, 0.465

0.012

 FPG

0.245

0.149, 0.341

 < 0.001

0.270

0.041, 0.499

0.022

 2h-PBG

0.299

0.204, 0.394

 < 0.001

0.251

0.022, 0.760

0.051

 LDL-C

0.236

0.140, 0.332

 < 0.001

0.243

0.089, 0.562

0.023

 HOMA-IR

0.194

0.036, 0.292

 < 0.001

− 0.046

− 0.264, 0.172

0.671

 Anti-platelet

− 0.156

− 0.254, − 0.058

0.002

− 0.281

− 0.525, − 0.037

0.025

 Statin

− 0.130

− 0.228, − 0.032

0.010

− 0.278

− 0.508, − 0.049

0.019

 Alcohol

− 0.116

− 0.214, − 0.012

0.021

− 0.193

− 0.386, 0.001

0.052

Annual TPV progression rate

 CV-HbA1C

0.243

0.078, 0.439

0.006

0.214

0.023, 0.405

0.029

 HbA1C

0.282

0.187, 0.377

 < 0.001

0.362

0.132, 0.591

0.003

 CV-FPG

0.265

0.069, 0.460

0.004

0.218

0.037, 0.399

0.019

 FPG

0.257

0.161, 0.352

 < 0.001

0.253

0.039, 0.467

0.022

 2h-FBG

0.316

0.221, 0.410

 < 0.001

0.215

0.024, 0.665

0.055

 LDL-C

0.230

0.133, 0.326

 < 0.001

0.295

0.106, 0.484

0.003

 HOMA-IR

0.205

0.108, 0.303

 < 0.001

− 0.122

− 0.324, 0.080

0.231

 Anti-platelet

− 0.170

− 0.267, − 0.073

0.001

− 0.311

− 0.540, − 0.082

0.009

 Statin

− 0.148

− 0.246, − 0.050

0.003

− 0.383

− 0.614, − 0.152

0.002

 Alcohol

− 0.116

− 0.215, − 0.017

0.021

− 0.201

− 0.407, − 0.041

0.058

  1. CV, coefficient of variation; FPG, fasting plasma glucose; PBG, postprandial blood glucose; HOMA-IR, homeostatic model assessment of insulin resistance; LDL-C, low density lipoprotein cholesterol
  2. aThe variables which got a level of P < 0.05 in the univariate analysis was presented in this table
  3. bMultivariate regression analysis was adjusted for age, sex, BMI, diabetes duration, smoking, alcohol consumption, hypertension, hypoglycemia rate, triglyceride, LDL-C, HDL-C, FPG, 2h-FBG, HbA1c, eGFR, UA, HOMA-IR, UACR, and medications